相关实验视频
Updated: Jan 13, 2026

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.9K
对于过敏护理的数字化和可持续转型的战略框架:EAACI的立场文件
Gavriela Feketea1, Inês Paciência2, Yoon-Seok Chang3
1Pediatric Allergy Outpatient Clinic, Karamandaneio Children's Hospital of Patra, Patras, Greece.
概括
整合数字健康和可持续实践可以改变儿科过敏护理. 该框架提高了诊断,监测和可访问性,同时减少了对环境的影响,促进了全球公平和气候负责任的医疗保健.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 数字健康数字健康
- 可持续的医疗保健 可持续的医疗保健
背景情况:
- 全球过敏疾病的流行率不断上升,特别是在儿童中.
- 传统过敏护理模式在诊断,监测和可持续性方面的局限性.
- 在过敏和免疫学中需要创新和可扩展的解决方案.
研究的目的:
- 提出一个整合数字健康创新的全球框架.
- 将可持续模式纳入过敏和免疫学护理.
- 专注于儿科和一般过敏服务.
主要方法:
- 基于专家意见的立场文件. 基于专家意见的立场文件.
- 通过关于数字健康和可持续实践的科学证据来告知.
- 文献审查和关于数字化转型,可持续性和合作的共识讨论.
主要成果:
- 利用数字健康 (移动健康,远程医疗,人工智能) 进行诊断,治疗和监测.
- 嵌入可持续实践以减少医疗保健碳排放.
- 促进国际合作,促进公平的数字过敏护理.
结论:
- 数字健康和可持续模式为过敏护理提供了变革性的潜力.
- 与环境,社会和治理 (ESG) 原则保持一致,确保质量,公平和气候责任.
- 为儿童过敏护理提供全球数字化和可持续转型的路线图.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K

